Filtros : "Nor, Jacques E." Limpar

Filtros



Refine with date range


  • Source: Journal of oral pathology & medicine. Unidade: FM

    Subjects: NEOPLASIAS DE CABEÇA E PESCOÇO, SALIVA, QUIMIOTERAPIA

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Luan Cesar et al. Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells. Journal of oral pathology & medicine, v. 51, n. 6, p. 553-562, 2022Tradução . . Disponível em: https://doi.org/10.1111/jop.13252. Acesso em: 11 jun. 2024.
    • APA

      Silva, L. C., Borgato, G. B., Wagner, V. P., Martins, M. D., Rocha, G. Z., Lopes, M. A., et al. (2022). Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells. Journal of oral pathology & medicine, 51( 6), 553-562. doi:10.1111/jop.13252
    • NLM

      Silva LC, Borgato GB, Wagner VP, Martins MD, Rocha GZ, Lopes MA, Santos-Silva AR, Castro Junior G de C, Kowalski LP, Nor JE. Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells [Internet]. Journal of oral pathology & medicine. 2022 ; 51( 6): 553-562.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1111/jop.13252
    • Vancouver

      Silva LC, Borgato GB, Wagner VP, Martins MD, Rocha GZ, Lopes MA, Santos-Silva AR, Castro Junior G de C, Kowalski LP, Nor JE. Cephaeline is an inductor of histone H3 acetylation and inhibitor of mucoepidermoid carcinoma cancer stem cells [Internet]. Journal of oral pathology & medicine. 2022 ; 51( 6): 553-562.[citado 2024 jun. 11 ] Available from: https://doi.org/10.1111/jop.13252
  • Source: PLOS ONE. Unidade: FO

    Assunto: NEOPLASIAS BUCAIS

    Acesso à fonteHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GIUDICE, Fernanda S. et al. Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer. PLOS ONE, v. 8, p. e58672, 2013Tradução . . Disponível em: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603970/pdf/pone.0058672.pdf. Acesso em: 11 jun. 2024.
    • APA

      Giudice, F. S., Pinto Júnior, D. dos S., Nor, J. E., Squarize, C. H., & Castilho, R. M. (2013). Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer. PLOS ONE, 8, e58672. Recuperado de http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603970/pdf/pone.0058672.pdf
    • NLM

      Giudice FS, Pinto Júnior D dos S, Nor JE, Squarize CH, Castilho RM. Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer [Internet]. PLOS ONE. 2013 ;8 e58672.[citado 2024 jun. 11 ] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603970/pdf/pone.0058672.pdf
    • Vancouver

      Giudice FS, Pinto Júnior D dos S, Nor JE, Squarize CH, Castilho RM. Inhibition of histone deacetylase impacts cancer stem cells and induces epithelial-mesenchyme transition of head and neck cancer [Internet]. PLOS ONE. 2013 ;8 e58672.[citado 2024 jun. 11 ] Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603970/pdf/pone.0058672.pdf

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024